Please enable Javascript
Adam Feldman, MD, MPH
Adam Feldman, MD, MPH, of Massachusetts General Hospital
Articles by Adam Feldman, MD, MPH
Lymph Node Selection, Adjuvant Considerations for Low-Grade UTUC
Katie S. Murray, DO, MS
Urothelial Carcinoma
|
June 9, 2024
The panel offers concluding thoughts on selection criteria for lymph node dissection in patients with low-grade UTUC.
View More
UGN-101 as an Alternative Treatment Approach to Surgery for Low-Grade UTUC
Katie S. Murray, DO, MS
Urothelial Carcinoma
|
June 9, 2024
The panel dissects a longitudinal follow-up of a multicenter study of UGN-101 as well as other 2024 AUA meeting data.
View More
Low-Grade UTUC Treatment Options for Recurrence After Ablation, Surgery
Katie S. Murray, DO, MS
Urothelial Carcinoma
|
June 9, 2024
The panel considers how to best treat patients with low-grade UTUC who experience disease recurrence post-surgery.
View More
Kidney-Sparing Approaches, Current Treatment Pathways for Low-Grade UTUC
Katie S. Murray, DO, MS
Urothelial Carcinoma
|
June 9, 2024
The panel highlights nephron-sparing approaches as well as current treatment pathways for low-grade UTUC.
View More
Deciphering and Determining Low-Grade UTUC: Diagnosis, Staging, and Grading
Katie S. Murray, DO, MS
Urothelial Carcinoma
|
June 9, 2024
The panel provides a disease state overview of low-grade UTUC, including considerations for diagnosis, staging, and grading.
View More
Risk Stratification in UTUC: Guidelines and Management Strategies
Katie S. Murray, DO, MS
Urothelial Carcinoma
|
June 9, 2024
The panel engages in a discussion related to risk stratification in UTUC, including identification of high-risk patients.
View More